Toi M - Search Results

1

Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.

Kuroi K, Toi M, Tsuda H, Kurosumi M, Akiyama F. Kuroi K, et al. Among authors: toi m. Breast Cancer. 2006;13(1):38-48. doi: 10.2325/jbcs.13.38. Breast Cancer. 2006. PMID: 16518061 Free article. Review.

2

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Am J Surg. 1992 Oct;164(4):323-6. doi: 10.1016/s0002-9610(05)80897-9. Am J Surg. 1992. PMID: 1357997

3

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization.

Toi M, Hattori T, Akagi M, Inokuchi K, Orita K, Sugimachi K, Dohi K, Nomura Y, Monden Y, Hamada Y, et al. Toi M, et al. Cancer. 1992 Nov 15;70(10):2475-83. doi: 10.1002/1097-0142(19921115)70:10<2475::aid-cncr2820701014>3.0.co;2-p. Cancer. 1992. PMID: 1423177 Clinical Trial.

4

[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients].

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1991 Jun;18(7):1181-5. Gan To Kagaku Ryoho. 1991. PMID: 1675844 Japanese.

5

Primary squamous cell carcinoma of the breast after cured Hodgkin's disease.

Kuroi K, Osaki A, Yamada H, Toi M, Toge T, Takimoto Y, Kuramoto A, Arihiro K, Inai K. Kuroi K, et al. Among authors: toi m. Surg Today. 1993;23(1):81-4. doi: 10.1007/BF00309006. Surg Today. 1993. PMID: 8461611

6

[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline].

Nagai S, Toi M, Kuroi K, Hayashi K, Tominaga T. Nagai S, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1999 Nov;26(13):2037-42. Gan To Kagaku Ryoho. 1999. PMID: 10584568 Clinical Trial. Japanese.

7

[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors].

Toi M, Matsumoto G, Bando H, Kuroi K. Toi M, et al. Gan To Kagaku Ryoho. 2000 Jul;27(8):1212-6. Gan To Kagaku Ryoho. 2000. PMID: 10945019 Japanese.

8

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K. Ueno T, et al. Among authors: toi m. Clin Cancer Res. 2000 Aug;6(8):3282-9. Clin Cancer Res. 2000. PMID: 10955814

9

[Angiogenesis as a prognostic factor of breast cancers].

Kuroi K, Toi M. Kuroi K, et al. Among authors: toi m. Nihon Rinsho. 2000 Apr;58 Suppl:435-41. Nihon Rinsho. 2000. PMID: 11026030 Review. Japanese. No abstract available.

10

Interleukin-4 and breast cancer.

Nagai S, Toi M. Nagai S, et al. Among authors: toi m. Breast Cancer. 2000;7(3):181-6. doi: 10.1007/BF02967457. Breast Cancer. 2000. PMID: 11029795 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters